An accusation against some A.I. companies that they are using the “open source” label too loosely.
OpenAI and the FDA are reportedly discussing AI for drug evaluations
- today, 5:09 PM
- techcrunch.com
- 0

An accusation against some A.I. companies that they are using the “open source” label too loosely.
No comments